Genetic variations of the ABCC2 gene in the Chinese, Malay, and Indian populations of Singapore

Drug Metabolism and Pharmacokinetics

Volumn 23, Issue 5, 2008, Pages 385-391

  Ho, Woon Fei ^a   Koo, Seok Hwee ^a   Yee, Jie Yin ^a   Lee, Edmund Jon Deoon ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

ABCC2; Clinical pharmacology; Human genetics; Pharmacogenetics; Single nucleotide polymorphism

Indexed keywords

ABC TRANSPORTER; ABC TRANSPORTER C2; MULTIDRUG RESISTANCE PROTEIN 2; UNCLASSIFIED DRUG; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 2;

5' UNTRANSLATED REGION; ADOLESCENT; ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; ETHNIC DIFFERENCE; FEMALE; GENETIC SCREENING; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOSITY; HUMAN; MALE; MUTATIONAL ANALYSIS; NUCLEIC ACID BASE SUBSTITUTION; NUCLEOTIDE SEQUENCE; PHARMACOGENETICS; POPULATION GENETICS; SEQUENCE ANALYSIS; SINGAPORE; ASIAN; CHINA; ETHNIC GROUP; ETHNOLOGY; GENETICS; INDIA; MALAYSIA; MIDDLE AGED; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; ETHNIC GROUPS; FEMALE; GENETIC VARIATION; HUMANS; INDIA; MALAYSIA; MALE; MIDDLE AGED; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; SINGAPORE;

EID: 58149288308     PISSN: 13474367     EISSN: 18800920     Source Type: Journal    
DOI: 10.2133/dmpk.23.385     Document Type: Article

References (30)

1. Suzuki, H. and Sugiyama, Y.: Single nucleotide polymorphisms in multidrug resistance associated protein 2 (MRP2/ABCC2): its impact on drug disposition. Adv. Drug Deliv. Rev., 54: 1311-1331 (2002).
2. Fardel, O., Jigorel, E., Le Vee, M. and Payen, L.: Physiological, pharmacological and clinical features of the multidrug resistance protein 2. Biomed. Pharmacother., 59: 104-114 (2005).
3. Taniguchi, K., Wada, M., Kohno, K., Nakamura, T., Kawabe, T., Kawakami, M., Kagotani, K., Okumura, K., Akiyama, S. and Kuwano, M.: A human canalicular multispecific organic anion transporter (cMOAT) gene is overexpressed in cisplatin-resistant human cancer cell lines with decreased drug accumulation. Cancer Res., 56: 4124-4129 (1996).
4. Tsujii, H., König, J., Rost, D., Stockel, B., Leuschner, U. and Keppler, D.: Exon-intron organization of the human multidrug-resistance protein 2 (MRP2) gene mutated in Dubin-Johnson syndrome. Gastroenterology, 117: 653-660 (1999).
5. Toh, S., Wada, M., Uchiumi, T., Inokuchi, A., Makino, Y., Horie, Y., Adachi, Y., Sakisaka, S. and Kuwano, M.: Genomic structure of the canalicular multispecific organic anion-transporter gene (MRP2/cMOAT) and mutations in the ATP-binding-cassette region in Dubin-Johnson syndrome. Am. J. Hum. Genet., 64: 739-746 (1999).
6. Hulot, J. S., Villard, E., Maguy, A., Morel, V., Mir, L., Tostivint, I., William-Faltaos, D., Fernandez, C., Hatem, S., Deray, G., Komajda, M., Leblond, V. and Lechat, P.: A mutation in the drug transporter gene ABCC2 associated with impaired methotrexate elimination. Pharmacogenet. Genomics, 15: 277-285 (2005).
7. Rau, T., Erney, B., Goares, R., Eschenhagen, T., Beck, J. and Langer, T.: High-dose methotrexate in pediatric acute lymphoblastic leukemia: impact of ABCC2 polymorphisms on plasma concentrations. Clin. Pharmacol. Ther., 80: 468-476 (2006).
8. Mor-Cohen, R., Zivelin, A., Rosenberg, N., Shani, M., Muallem, S. and Seligsohn, U.: Identification and functional analysis of two novel mutations in the multidrug resistance protein 2 gene in Israeli patients with Dubin-Johnson syndrome. J. Biol. Chem., 276: 36923-36930 (2001).
9. Itoda, M., Saito, Y., Soyama, A., Saeki, M., Murayama, N., Ishida, S., Sai, K., Nagano, M., Suzuki, H., Sugiyama, Y., Ozawa, S. and Sawada, Ji J.: Polymorphisms in the ABCC2 (cMOAT/MRP2) gene found in 72 established cell lines derived from Japanese individuals: an association between single nucleotide polymorphisms in the 5′-untranslated region and exon 28. Drug Metab. Dispos., 30: 363-364 (2002).
10. Suzuki, H. and Sugiyama, Y.: Excretion of GSSG and glutathione conjugates mediated by MRP1 and cMOAT/MRP2. Semin. Liver Dis., 18: 359-376 (1998).
11. König, J., Nies, A. T., Cui, Y., Leier, I. and Keppler, D.: Conjugate export pumps of the multidrug resistance protein (MRP) family: localization, substrate specificity, and MRP2-mediated drug resistance. Biochim. Biophys. Acta., 1461: 377-394 (1999).
12. Keppler, D. and Konig, J.: Hepatic secretion of conjugated drugs and endogenous substances. Semin. Liver Dis., 20: 265-272 (2000).
13. Sasaki, M., Suzuki, H., Ito, K., Abe, T. and Sugiyama, Y.: Transcellular transport of organic anions across a double-transfected Madin-Darby canine kidney II cell monolayer expressing both human organic anion-transporting polypeptide (OATP2/SLC21A6) and Multidrug resistance-associated protein 2 (MRP2/ABCC2). J. Biol. Chem., 277: 6497-6503 (2002).
14. Kivistö, K. T. and Niemi, M.: Influence of drug transporter polymorphisms on pravastatin pharmacokinetics in humans. Pharm. Res., 24: 239-247 (2007).
15. Niemi, M., Arnold, K. A., Backman, J. T., Pasanen, M. K., Gödtel-Armbrust, U., Wojnowski, L., Zanger, U. M., Neuvonen, P. J., Eichelbaum, M., Kivisto, K. T. and Lang, T.: Association of genetic polymorphism in ABCC2 with hepatic multidrug resistance-associated protein 2 expression and pravastatin pharmacokinetics. Pharmacogenet. Genomics, 16: 801-808 (2006).
16. Choi, J. H., Ahn, B.M., Yi, J., Lee, J. H., Lee, J. H., Nam, S.W., Chon, C. Y., Han, K. H., Ahn, S. H., Jang, I.J., Cho, J. Y., Suh, Y., Cho, M. O., Lee, J. E., Kim, K. H. and Lee, M. G.: MRP2 haplotypes confer differential susceptibility to toxic liver injury. Pharmacogenet. Genomics, 17: 403-415 (2007).
17. Izzedine, H., Hulot, J. S., Villard, E., Goyenvalle, C., Dominguez, S., Ghosn, J., Valantin, M. A., Lechat, P. and Deray, A. G.: Association between ABCC2 gene haplotypes and tenofovir-induced proximal tubulopathy. J. Infect. Dis., 194: 1481-1491 (2006).
18. Borst, P., Evers, R., Kool, M. and Wijnholds, J.: The multidrug resistance protein family. Biochim. Biophys. Acta., 1461: 347-357 (1999).
19. Cui, Y., Koanig, J., Buchholz, J. K., Spring, H., Leier, I. and Keppler, D.: Drug resistance and ATP-dependent conjugate transport mediated by the apical multidrug resistance protein, MRP2, permanently expressed in human and canine cells. Mol. Pharmacol., 55: 929-937 (1999).
20. Hoffmann, U. and Kroemer, H. K.: The ABC transporters MDR1 and MRP2: multiple functions in disposition of xenobiotics and drug resistance. Drug Metab. Rev., 36: 669-701 (2004).
21. Ito, S., Ieiri, I., Tanabe, M., Suzuki, A., Higuchi, S. and Otsubo, K.: Polymorphism of the ABC transporter genes, MDR1, MRP1 and MRP2/cMOAT, in healthy Japanese subjects. Pharmacogenetics, 11: 175-184 (2001).
22. Saito, S., Iida, A., Sekine, A., Miura, Y., Ogawa, C., Kawauchi, S., Higuchi, S. and Nakamura, Y.: Identification of 779 genetic variations in eight genes encoding members of the ATP-binding cassette, subfamily C (ABCC/MRP/CFTR). J. Hum. Genet., 47: 147-171 (2002).
23. Leschziner, G., Zabaneh, D., Pirmohamed, M., Owen, A., Rogers, J., Coffey, A. J., Balding, D. J., Bentley, D. B. and Johnson, M. R.: Exon sequencing and high resolution haplotype analysis of ABC transporter genes implicated in drug resistance. Pharmacogenet. Genomics, 16: 439-450 (2006).
24. Koo, S. H., Ho, W. F. and Lee, E. J.: Genetic polymorphisms in KCNQ1, HERG, KCNE1 and KCNE2 genes in the Chinese, Malay and Indian populations of Singapore. Br. J. Clin. Pharmacol., 61: 301-308 (2006).
25. Han, J. Y., Lim, H. S., Yoo, Y. K., Shin, E. S., Park, Y. H., Lee, S. Y., Lee, J. E., Lee, D. H., Kim, H. T. and Lee, J. S.: Associations of ABCB1, ABCC2, and ABCG2 polymorphisms with irinotecan-pharmacokinetics and clinical outcome in patients with advanced non-small cell lung cancer. Cancer, 110: 138-147 (2007).
26. Wojnowski, L., Kulle, B., Schirmer, M., Schluter, G., Schmidt, A., Rosenberger, A., Vonhof, S., Bickeboller, H., Toliat, M. R., Suk, E. K., Tzvetkov, M., Kruger, A., Seifert, S., Kloess, M., Hahn, H., Loeffler, M., Nurnberg, P., Pfreundschuh, M., Trumper, L., Brockmoller, J. And Hasenfuss, G.: NAD(P)H oxidase and multidrug resistance protein genetic polymorphisms are associated with doxorubicin-induced cardiotoxicity. Circulation, 112: 3754-3762 (2005).
27. Floreani, A., Carderi, I., Variola, A., Rizzotto, E. R., Nicol, J. and Bergasa, N. V.: A novel multidrug-resistance protein 2 gene mutation identifies a subgroup of patients with primary biliary cirrhosis and pruritus. Hepatology, 43: 1152-1154 (2006).
28. Meier, Y., Pauli-Magnus, C., Zanger, U. M., Klein, K., Schaeffeler, E., Nussler, A. K., Nussler, N., Eichelbaum, M., Meier, P. J. and Stieger, B.: Interindividual variability of canalicular ATP-binding-cassette (ABC)-transporter expression in human liver. Hepatology, 44: 62-74 (2006).
29. Zhou, Q., Sparreboom, A., Tan, E. H., Cheung, Y. B., Lee, A., Poon, D., Lee, E. J. and Chowbay, B.: Pharmacogenetic profiling across the irinotecan pathway in Asian patients with cancer. Br. J. Clin. Pharmacol., 59: 415-424 (2005).
30. Zamboni, W. C., Ramanathan, R. K., McLeod, H. L., Mani, S., Potter, D.M., Strychor, S.,Maruca, L. J., King, C. R., Jung, L. L., Parise, R. A., Egorin, M. J., Davis, T. A. and Marsh, S.: Disposition of 9-nitrocamptothecin and its 9-aminocamptothecin metabolite in relation to ABC transporter genotypes. Invest. New Drugs, 24: 393-401 (2006).